The transactions highlighted below are representative of Greenhill engagements. In addition, the Firm has completed many engagements that were not publicly-disclosed.
Recent Transactions
Sort By

Pacific Drilling

Advised Pacific Drilling, an international provider of offshore drilling services, on its pre-arranged Chapter 11 restructuring

Biogix, Inc.

Advised Biogix, Inc., a leader in the development, research and distribution of clinically tested menopause and perimenopause supplements in the U.S. under the flagship brand Amberen, on its sale to Alliance Pharma plc

Cirque du Soleil

Advised the Company on its CCAA and Ch.15 proceedings and $1.5bn sale through a Sale and Investment Solicitation Process (SISP)

Vorboss Limited

Advised Vorboss Limited, a London-based fibre operator, on its sale to Fern Fibre Limited / Octopus Investments, securing a funding commitment enabling an ambitious fibre deployment program

iQor Holdings Inc.

Advised the ad-hoc Cross-Holder Group of lenders on the fully consensual Prepackaged Plan of Reorganization of iQor Holdings Inc., a business process outsourcing company

Gannett Co., Inc.

Advised Gannett Co., Inc., a news media and marketing solutions company, on the refinancing of ~$500mm of its term loan with convertible notes

Learning Materials for the K-12 Segment in Spain

Advising Sanoma Oyj (HEL: SAA1V), a European learning and media company listed on Nasdaq Helsinki, on the acquisition of Santillana Spain, a leading Spanish provider of K-12 learning materials, from Promotora de Informaciones S.A. (Grupo Prisa, BME: PRS)

Axión Group

Advised AMP Capital on the sale of its portfolio company Axión Group, a leading independent broadcasting and telecommunications infrastructure provider in Spain, to Asterion Industrial Partners, a Spanish infrastructure fund

Cosmetic applications endolysin

Advised Micreos, a fast-growing biotechnology company, on a long-term license agreement with L’Oréal for one of Micreos’ phage-based active ingredients, SA.100

Akorn, Inc.

Advised Ad Hoc Group of First Lien Term Loan Lenders on Akorn’s in-court recapitalization

VX Fiber

Advised VX Fiber, an international infrastructure and technology business focused on Fibre-to-the-Home networks, on its sale to the infrastructure fund AMP Capital

Surgery Partners’ Anesthesia Services

Advised Surgery Partners, a leading owner and operator of surgical facilities, on the divestiture of its anesthesia services business to NorthStar Anesthesia

Unit Corporation

Advised the Ad Hoc Group of Noteholders on the prepackaged in-court restructuring of Unit Corporation

340B Link

Advising Omnicell, a leading provider of medication management solutions and adherence tools for health systems and pharmacies, on the acquisition of the 340B Link business from Pharmaceutical Strategies Group (PSG)

Range Resources Terryville Assets

Advised Castleton Resources, a Houston, TX based, privately held oil and gas operator, on its acquisition of Range Resources’ Terryville Assets. As part of the transaction, Castleton Resources will change its name to “TG Natural Resources LLC” by late March 2021. Range Resources (NYSE: RRC) is a Fort Worth, TX based E&P company with primary operations in the Marcellus Shale formation.

Community Fibre Limited

Advised Warburg Pincus LLC and Deutsche Telekom Capital Partners on the acquisition of a majority stake in CommunityFibre Limited, a leading full fibre network infrastructure platform in UK

PG&E Corporation

Advised Pension Benefit Guaranty Corporation (“PBGC”) in connection with PG&E’s in-court restructuring

Cello Health plc

Advised Cello Health, a global healthcare-focused advisory firm, on a recommended cash offer for its entire issued share capital from Arsenal Capital Partners, a specialised private equity firm based in the United States

Equity stake in Bupa Arabia

Advising Bupa, a leading international healthcare group, on the increase of its stake in Bupa Arabia, the largest health insurance provider in the Kingdom of Saudi Arabia

Global collaboration agreement with Genmab A/S

Advised AbbVie, Inc, an NYSE-listed global biopharmaceutical company, on a broad collaboration with Genmab A/S, a leading Danish-listed biotechnology company, to jointly develop and commercialise three next-generation bispecific antibody programs

Cerner RevWorks

Advised Cerner Corporation, a leader in healthcare information technology, on its sale of its RevWorks revenue cycle management services business to R1 RCM, a leading provider of technology-enabled RCM services

Abacus Health Products, Inc.

Advised Abacus Health Products, Inc., a leader in over-the-counter (“OTC”) topical products combining active pharmaceutical ingredients with cannabidiol (“CBD”) hemp extract, on its sale to the Charlotte’s Web Holdings, Inc., a market leader in hemp-derived CBD wellness products.

Centrifuge and processing equipment business of Koki Holdings Co., Ltd.

Advised Eppendorf AG, a leading family-owned life science company, on the acquisition of the centrifuge and processing equipment business of KKR-owned Koki Holdings Co., Ltd., a manufacturer of power tools and centrifuge and processing equipment

Global rights (excluding North America) to ThermaCare (United Kingdom)

Advised GlaxoSmithKline plc (“GSK”), the UK listed international pharmaceutical and consumer healthcare company, on the divestiture of the global rights (excluding North America) for ThermaCare, including a dedicated manufacturing facility based in Albany, Georgia, USA, to Angelini Pharma

Asia and US rights to Physiogel

Advised GlaxoSmithKline plc (“GSK”), the UK listed international pharmaceutical and consumer healthcare company, on the divestiture of the rights to Physiogel Asia and the US to Korea-based LG Household & Health Care Ltd